Washe A.P.,Rovira i Virgili University |
Lozano-Sanchez P.,Integrated Quality |
Bejarano-Nosas D.,Rovira i Virgili University |
Katakis I.,Rovira i Virgili University
Electrochimica Acta | Year: 2013
Screen printed carbon electrodes provide attractive opportunity for the development of miniaturized low cost electrochemical sensors. However, the electrodes display very low level of electrochemical performance due to the nonelectroactive components in the ink formulation and relatively low graphitic carbon content imposed by the constraints of screen-printing. In this work, selective etching action of a judiciously selected organic solvent was envisaged to improve the electrochemical characteristics of the electrodes. The procedure involves soaking the electrode strips in N,N-dimethylformamide (DMF) for just minutes of etching followed by drying. Five minutes DMF treated electrode, for instance, showed a 100-fold increase in the heterogeneous charge transfer kinetics compared to the untreated electrodes. The effective area of the solvent treated electrode was 57-fold of its apparent geometric area. The solvent treated electrodes also showed a dramatically decreased charge transfer resistance from ca. 18,000 Ω to 180 Ω. The results of surface examination using scanning probe microscopy and electrochemical impedance spectroscopy revealed enhancement in the porosity of the solvent treated electrodes. The procedure is versatile and applicable to other screen-printed electrodes such as gold, silver or silver/silver chloride to improve the performances characteristics including stability. The ability to activate several electrodes simultaneously and multiple re-usability of the solvent makes this approach cost effective and very promising to facilitate mass production of miniaturized and disposable electrochemical sensors. © 2012 Elsevier Ltd. All rights reserved.
Freeman E.,University of Southern Maine |
McGuire C.A.,Integrated Quality |
McGuire C.A.,University of Southern Maine |
Thomas J.W.,University of Southern Maine |
Thayer D.A.,University of Michigan
Medical Care | Year: 2014
Background: Persons with behavioral disorders incur higher healthcare costs. Although they utilize behavioral health (BH) services others do not, they also have higher utilization of medical services Objectives: To determine the degree to which higher costs for persons with BH disorders are attributable to utilization of BH services, multiple chronic medical conditions (CMCs) or other issues specific to populations with BH disorders. Research Design: Data base consisted of claims for 63,141 Medicaid beneficiaries, 49% of whom had one of 5 categories of BH disorder. Generalized linear models were used to identify relative impact of demographics, BH status, multiple CMCs and primary care access on total, behavioral, nonbehavioral, and medical/surgical costs. Results: Number of CMCs was associated with significant increases in all cost categories, including behavioral costs. Presence of any BH disorder significantly influenced these same costs, including those not associated with BH care. Effect size in each cost category varied by BH group. Conclusions: BH status has a large impact on all healthcare costs, including costs of medical and other non-BH services. The number of CMCs affects BH costs independent of BH disorder. Results suggest that costs might be reduced through better integration of behavioral and medical health services. © 2014 by Lippincott Williams & Wilkins.
Anderson K.,Integrated Quality |
Foster M.M.,Integrated Quality |
Freeman C.R.,University of Queensland |
Scott I.A.,Integrated Quality
The Medical journal of Australia | Year: 2016
Co-creation (or co-design) represents the highest form of stakeholder engagement, but it can be infeasible to co-create with all stakeholders through all stages of a research project. The choice of stakeholders for co-design will depend on the study purpose and context of change. For this deprescribing pilot study, general practitioners were recognised as a critical gateway for co-creation, with patients' perspectives of the deprescribing process to be assessed in the evaluation of the pilot.
Teodoro A.,Integrated Quality
Occupational Safety and Hygiene IV - Selected, Extended and Revised Contributions from the International Symposium Occupational Safety and Hygiene, 2016 | Year: 2016
The mechanical handling of security charges has as its central point to ensure that the equipment that move are suitable either to load or working conditions; that their certification and maintenance are properly secured and within their expiration dates; that operators have specific training and are properly familiar with how to operate the machines safely, as well as the verification of balances and moorings of cargo. Their activities must be supervised by competent technicians which include safety technicians. The main objective of this article is to highlight the key measures that a security technician should take to ensure that the movement of cargo and people on cranes, forklift trucks or lifting platforms run safely avoiding the many accidents that occur annually. © 2016 Taylor & Francis Group, London.
McAlister F.A.,University of Alberta |
Bakal J.A.,University of Alberta |
Bakal J.A.,Alberta Health Services |
Majumdar S.R.,University of Alberta |
And 5 more authors.
BMJ Quality and Safety | Year: 2014
Purpose: Whether improving the efficiency of hospital care will worsen post-discharge outcomes is unclear. We designed this study to evaluate the General Internal Medicine (GIM) Care Transformation Initiative implemented at one of the seven teaching hospitals in the Canadian province of Alberta. Methods: Controlled before-after study of GIM patients hospitalised at the University of Alberta Hospital (UAH, intervention site, n=1896) or the six other teaching hospitals in Alberta - three in Edmonton (intra-regional controls (IRC), n=4550) and three in Calgary (extra-regional controls (ERC), n=4095). The primary effectiveness outcome was risk-adjusted length of stay (LOS) and the primary safety outcome was 'mortality during index hospitalisation or all-cause readmission or death within 30-days of discharge'. Results: LOS for GIM patients decreased by 0.68 days at Alberta teaching hospitals between 2009 and 2012; GIM patients hospitalised at the UAH exhibited a further 20%relative decline in adjusted LOS (total reduction=1.43 days, 95% CI 0.94 to 1.92 days) from PRE to POST. Interrupted time series (ITS) confirmed that the 1.43 day reduction at the UAH was statistically significant (level change p=0.003), while the declines at the IRC (p=0.37) and ERC (p=0.45) were not. Our safety outcome did not change for UAH patients (18.4% PRE-intervention vs 17.8%POST-intervention, adjusted OR 1.02 (95%CI 0.80 to 1.31), p=0.42 on ITS), nor for those hospitalised at the IRC (p=0.33) or the ERC (p=0.73) sites. Conclusions: The Care Transformation Initiative was associated with substantial reductions in LOS without increasing post-discharge events commonly quoted as proxies for quality.
Integrated Quality | Date: 2015-09-15
Chemicals used in industry and science, reagents and biosensor active solutions for controlling and detecting contaminants in industrial, agricultural, cosmetic and pharmaceutical products, all these products being related to diagnostics and for non-medical purposes; chemical, biochemical and biological assays, and reagents for industrial scientific, agricultural, horticultural and forestry purposes; chemical reagents for the detection of pathogens in food and the environment; growth stimulants and inhibitors, enrichment broths and agars for use in cell culture for the use in the biotechnological industry and not for medical or veterinary use; cell culture media, namely, broths and agars not for medical or veterinary purposes; growth stimulants and inhibitors, enrichment broths and agars for use in for cell culture for the use thereof in non-medical research laboratories; chemical reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes. Reagents and diagnostic media for bacteriological cultures and biosensor active solutions for medical and veterinary diagnosis, all these products being related to diagnostics; chemical, biochemical and biological assays, and reagents for medical and veterinary purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes. Scientific, measuring and checking apparatus and instruments, namely, laboratory incubators, laboratory shakers, laboratory stirrers, magnets, electrochemical devices and sensors namely, potentiostats, ammeters, and impedance meters, all for biological activity for non-medical purposes.
Zorrilla I.,Integrated Quality |
Martinez R.,Integrated Quality |
Taggart M.A.,University of the Highlands and Islands |
Richards N.,Working Dogs for Conservation
Conservation Biology | Year: 2015
Exposure to residues of the nonsteroidal anti-inflammatory drug (NSAID) diclofenac present in livestock carcasses has caused extensive declines in 3 Gyps vulture species across Asia. The carcass of a wild Eurasian Griffon Vulture (Gyps fulvus) was found in 2012 on an Andalucian (Spain) game hunting reserve and examined forensically. The bird had severe visceral gout, a finding consistent with Gyps vultures from Asia that have been poisoned by diclofenac. Liver and kidney samples from this Eurasian Griffon Vulture contained elevated flunixin (an NSAID) levels (median = 2.70 and 6.50 mg/kg, respectively). This is the first reported case of a wild vulture being exposed to and apparently killed by an NSAID outside Asia. It is also the first reported instance of mortality in the wild resulting from environmental exposure to an NSAID other than diclofenac. © 2014 Society for Conservation Biology.
Integrated Quality | Date: 2016-03-16
The present specification discloses methods of detecting a pathogen of interest, components useful in carrying out these methods, including a pre-enrichment media, and enrichment media and a detection solution and kits thereof.
PubMed | University of Alberta, University of Saskatchewan and Integrated Quality
Type: Journal Article | Journal: Journal of advanced nursing | Year: 2016
A discussion of how nurses can contribute to and lead improvement science activities in health care.Quality failures in health care have led to the urgent need for healthcare quality improvement. However, commonly quality improvement interventions proceed to practice implementation without rigorous methods or sufficient empirical evidence. This lack of evidence for quality improvement has led to the development of improvement science, which embodies quality improvement research and quality improvement practice. This paper discusses how the discipline of nursing and the nursing profession possesses many strengths that enable nurses to lead and to play an integral role in improvement science activities. However, we also discuss that there are insufficiencies in nursing education that require attention for nurses to truly contribute to and lead improvement science in health care.Discussion paper.This paper builds on a collection of our previous work, a 12-month scoping review (March 2013-March 2014), baseline study on a quality improvement management system (Lean), interviews with nurses on quality improvement implementation and supporting literature.This paper highlights how nurses have the philosophical, theoretical, political and ethical positioning to contribute to and lead improvement science activities. However up to now, the potential for nurses to lead improvement science activities has not been fully used.We suggest that one starting point is to include improvement science in nursing education curricula. Specifically, there needs to be increased focus on the nursing roles and skills needed to contribute to and lead healthcare improvement science activities.
PubMed | University of Queensland and Integrated Quality
Type: Journal Article | Journal: The Medical journal of Australia | Year: 2016
Co-creation (or co-design) represents the highest form of stakeholder engagement, but it can be infeasible to co-create with all stakeholders through all stages of a research project. The choice of stakeholders for co-design will depend on the study purpose and context of change. For this deprescribing pilot study, general practitioners were recognised as a critical gateway for co-creation, with patients perspectives of the deprescribing process to be assessed in the evaluation of the pilot.